55th Annual Meeting of the Environmental Mutagenesis and Genomics Society (EMGS)

Science from the HESI Genetic Toxicology (GTTC) and Emerging Systems Toxicology for the Assessment of Risk (eSTAR) committees will be well represented at the 55th Annual Meeting of the Environmental Mutagenesis and Genomics Society (EMGS) in Palm Springs, California.

Reach out to Connie Chen or Raechel Puglisi if you have any questions!

Saturday September 7

• Workshop 1 “Sequencing the Future: Understanding Error-Corrected Sequencing” is organized by Connie Chen & Meagan Myers. Shaofei Zhang (Pfizer) will be presenting work from GTTC and Alberto del Rio (GentiBio) will be presenting work for CT-TRACS.

Sunday September 8

• Symposium 2: Towards the development of a global genotoxocity AOP network will feature several GTTC speakers and activities – Wen Sun (Pfizer) will present on Topoisomerase II and Dan Roberts (Toxys) will present on Tubulin and Kinase inhibitors.

Monday September 9

• Poster Session 2: Understanding the Carcinogenic Potential of Nitrosamines: Developing an In vivo Verification Strategy for the Ames, Comparative Analysis of In Vitro/In Vivo Mutagenicity Testing for NDSRIs presented by Tetyana Cheairs on behalf of the HESI GTTC Nitrosamine Research Program
• Poster Session 2: Optimizing the Ames Assay for Nitrosamine Testing: Concordance Results of a HESI Multi-Sector Ring Trial presented by Tetyana Cheairs on behalf of the HESI GTTC Nitrosamine Research Program

Tuesday, September 10

• Symposium 9: Under the Spotlight: High-Profile Chemicals will feature an overview of the HESI GTTC Nitrosamine Research Program presented by Tetyana Cheairs (NYMC)
• Platform 3: Sequencing the Genome and Beyond will include a presentation by Shaofei Zhang (Pfizer) on the GTTC reconstruction project and James Alcaraz (U Ottawa) on cancer driver gene mutations for the eSTAR committee.